Randomized controlled study of different pharmaceutical care modes for patients with chronic diseases by clinical pharmacists

INTERVENTION: MTMs+Routine diagnosis and treatment group:Medicine treatment management mode service;Routine diagnosis and treatment group :Routine diagnosis and treatment; CONDITION: Chronic disease PRIMARY OUTCOME: Reduction rate of irrational drug use;Unreasonable number of drug use per capita; SECONDARY OUTCOME: Compliance rate of clinical indicators;Incidence of adverse drug reactions;Prescription adjustment rate;Average monthly drug cost;Number of hospitalizations;Patient satisfaction;Implementation rate of pharmaceutical recommendations;Drug compliance score; INCLUSION CRITERIA: ? At least one chronic disease (such as hypertension, type 2 diabetes, hyperlipidemia, coronary heart disease, chronic obstructive pneumonia, etc.); ? The number of long‐term (continuous use of 28 days or more) combined use of chemicals = 3; ? It can provide laboratory examination indicators such as blood biochemistry and blood routine in the past two weeks, and has various main clinical examination results related to the chronic disease it suffers from; ? The patient voluntarily matched and signed the informed consent form.